Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2015

Every FDA drug recall initiated in 2015, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,733 recalls, newest first.

Class I · High risk

5% Dextrose Injection

Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0338-0017-02 D-1209-2015
Class III · Low risk

Fluorescein Sodium Ophthalmic Strips USP

Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of fluorescein present in the strips.

Terminated Wrong potency / content Nomax Inc NDC 17478-404-01 D-0963-2015
Class III · Low risk

Rose Bengal GloStrips

Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of rose bengal present in the strips.

Terminated Wrong potency / content Nomax Inc NDC 51801-004-01 D-0962-2015
Class III · Low risk

Fluorescein Sodium Ophthalmic Strips USP

Failed Content Uniformity Specifications: The product may not meet finished product release specifications, including the uniformity of dosage due to a packaging degradation related to the adhesive component of the paper pouch that can impact the level of fluorescein present in the strips.

Terminated Wrong potency / content Nomax Inc NDC 51801-003-01 D-0961-2015
Class II · Moderate risk

5% Dextrose Injection

Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-0017-04 D-0426-2015
Class II · Moderate risk

0.9% Sodium Chloride Injection

Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-0049-03 D-0425-2015

Recalls by year